Internal Medicine · San Francisco, CA
NPI
1841308517
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
400 Parnassus Ave # A502
San Francisco, CA, 94143
Phone (415) 353-2421
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
317 services
Medicare patients, 2024
84
Average age 72
Drug cost, 2024
$1.4M
299 prescriptions
Company payments, 2025
$20.71
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter H Sayre was code 99215 (office e&m - established), 140 times for 49 patients. In total Peter H Sayre billed 317 services in 18 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 140 | 49 | $118.92 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 110 | 42 | $14.53 | $1,598 |
| 99205 Office E&M - New | Facility | 18 | 18 | $161.40 | $2,905 |
| 38222 Other Organ Systems | Facility | 13 | 11 | $51.37 | $668 |
By year: 2022 $34K for 359 services; 2023 $24K for 492 services; 2024 $24K for 317 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter H Sayre prescribed most often to Medicare patients was Acyclovir, with 30 prescriptions and refills. In total Peter H Sayre wrote 299 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 30 | 50 | Under 11 | $463 |
| Jakafi Ruxolitinib Phosphate | 26 | 26 | Under 11 | $397K |
| Sprycel Dasatinib | 14 | 14 | Under 11 | $106K |
| Voriconazole Generic | 13 | 13 | Under 11 | $4,024 |
| Rydapt Midostaurin | 12 | 12 | Under 11 | $266K |
Brand drugs: 104 claims; generic drugs: 195 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter H Sayre $20.71 ($20.71 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $20.71.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $20.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.